Conatus Pharmaceuticals Inc. To Report Fourth Quarter And Full Year 2013 Financial Results
3/21/2014 8:55:47 AM
SAN DIEGO, March 20, 2014 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2013, after the market close on Thursday, March 27, 2014. Conatus will host a conference call and audio webcast at 4:30 p.m. Eastern Time on Thursday, March 27, 2014, to discuss the financial results and provide a corporate update.
Help employers find you! Check out all the jobs and post your resume.